Using the holoreceptor from human placenta and the soluble kinase expressed in Sf9 insect cells (baculovirus system), we are characterizing the dual specificity of the insulin receptor and its effects on signal transduction. With the help of HPLC phosphopeptide mapping, we are able to analyze specific phosphorylation sites in the insulin receptor and its substrates. By site-directed mutagenesis, we created a number of mutated receptor kinases to determine the influence of single amino acid residues. Recombinant fragments of IR domains and in vivo substrates (IRS-1, Gab-1) help to understand how the receptor gets activated and interacts with downstream signaling molecules. We have cloned and expressed a glutathione S-transferase (GST)-dimerized insulin receptor kinase as a novel model for the holoreceptor.
In addition to the insulin receptor, we are studying soluble tyrosine kinases of the Insulin Like Growth Factor-1 Receptor (IGF-1R), the Epidermal Growth Factor Receptor (EGFR) and the BDNF / NT-3 Growth Factors Receptor (TrkB). All of these show a dual specificity, leading to the hypothesis that serine phosphorylation of receptor tyrosine kinases might be a general phenomenon. The IGF-1R kinase has been dimerized by GST in the same way as the insulin receptor.
Interested?